Loading…
Loading…
Beijing has run a similar demonstration-to-scale-up industrial-policy playbook for semiconductors, NEVs and future energy (see BDA future-energy measures, 2025-12-11, in this register). This notice applies the same template to medical devices, but at municipal rather than district level — six city-wide departments co-issued it, versus the single-district BDA management committee for the future-energy package, and per-project caps are 60-100x higher (RMB 30-50m here vs. RMB 150k-500k for BDA future energy). The policy spans the entire value chain rather than one technology basket: R&D, clinical registration, manufacturing infrastructure, digital/AI transformation, and — notably — outbound regulatory approval support to help Beijing-made devices clear foreign (FDA, CE, etc.) registration and enter export markets.
Severity is set to 3 (above the district-level BDA precedent's 2) because of the municipal-level, six-department joint issuance, materially larger per-project subsidy caps (up to RMB 50m ≈ USD 7m per project), and the inclusion of an explicit outbound/export-support line item, which extends the policy's effect beyond the domestic market. severity_basis is quant: the source discloses concrete subsidy percentages and RMB caps across all 15 measures.
running sector-specific medical-device/biomedical subsidy stacks alongside Shanghai Huangpu (translational medicine, BCI) and the national State Council Order 818 biomedical framework already in the register.
export-competitiveness lever — Beijing device makers now receive state support specifically to clear foreign regulatory approval, a mechanism that could accelerate Chinese medical-device import penetration in the US/EU/emerging markets.
to other Beijing industrial-policy notices in the register (BDA future energy, BDA automotive) rather than a one-off grant.
caps. Watch for a follow-up budget-execution notice disclosing total program spend.
named-company disclosures in Beijing municipal budget reporting.